Obexia AG
Development of breakthrough therapies for loss of body weight and muscle mass and anorexia
Obexia "the weight switch company" is a biopharmaceutical startup company that focuses on the development of innovative breakthrough therapies for cachexia (loss of body weight and muscle mass) and anorexia (appetite loss). Our particular focus is cancer cachexia and anorexia, also known as wasting syndrome, a frequent condition associated with a significant unmet medical need and early death.
Only registered users have access to funding information.
Please log in or register to continue. Registration is free.
No news
No milestones
No Jobs
No videos and documents
No Awards
Obexia AG
Development of breakthrough therapies for loss of body weight and muscle mass and anorexia
Website:
obexia.com
Headquarter:
Basel
Foundation Date:
December 2012
Technology:
- Biotech
Sectors:
- Screening